Paper7650486
Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
Aramburu J and 3 others. J Exp Med, 1995. Cited by 125 papers, by iCite.
Cite this record
ConductScience Library. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. Papers, record 7650486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7650486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Gene Expression Regulation | Major topic |
| Killer Cells, Natural | Major topic |
| Nuclear Proteins | Major topic |
| Receptors, IgG | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Antigen-Antibody Complex | |
| B-Lymphocytes | |
| Base Sequence | |
| Cell Line, Transformed | |
| Chlorocebus aethiops | |
| Cyclosporine | |
| Cytokines | |
| Humans | |
| Interleukin-12 | |
| Interleukin-2 | |
| Leukemia-Lymphoma, Adult T-Cell | |
| Ligands | |
| Lymphocyte Activation | |
| Mice | |
| Molecular Sequence Data | |
| NFATC Transcription Factors | |
| Tumor Cells, Cultured |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA37155 | NCI NIH HHS | United States | R01CA037155 | PubMed and NIH | NIH RePORTER |
| CA45284 | NCI NIH HHS | United States | R01CA045284 | PubMed and NIH | NIH RePORTER |
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6828386 | Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. | Nucleic Acids Res | 1983 | https://conductscience.org/library/papers/6828386 | PubMed |
| 2 | 7739550 | NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7739550 | PubMed |
| 3 | 2831292 | Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. | J Exp Med | 1988 | https://conductscience.org/library/papers/2831292 | PubMed |
| 4 | 2846696 | Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. | J Immunol | 1988 | https://conductscience.org/library/papers/2846696 | PubMed |
| 5 | 2536067 | Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes. | J Exp Med | 1989 | https://conductscience.org/library/papers/2536067 | PubMed |
| 6 | 2493506 | Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. | J Immunol | 1989 | https://conductscience.org/library/papers/2493506 | PubMed |
| 7 | 2683611 | Biology of natural killer cells. | Adv Immunol | 1989 | https://conductscience.org/library/papers/2683611 | PubMed |
| 8 | 1702384 | The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. | EMBO J | 1990 | https://conductscience.org/library/papers/1702384 | PubMed |
| 9 | 1707162 | The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. | Nucleic Acids Res | 1991 | https://conductscience.org/library/papers/1707162 | PubMed |
| 10 | 2054113 | Lymphokine-activated killer cells, natural killer cells and cytokines. | Curr Opin Immunol | 1991 | https://conductscience.org/library/papers/2054113 | PubMed |
| 11 | 1712901 | The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. | Mol Cell Biol | 1991 | https://conductscience.org/library/papers/1712901 | PubMed |
| 12 | 1715516 | Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. | Nature | 1991 | https://conductscience.org/library/papers/1715516 | PubMed |
| 13 | 1910686 | Fc receptors. | Annu Rev Immunol | 1991 | https://conductscience.org/library/papers/1910686 | PubMed |
| 14 | 1730723 | A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence "cytokine-1". | J Biol Chem | 1992 | https://conductscience.org/library/papers/1730723 | PubMed |
| 15 | 1740667 | The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. | J Exp Med | 1992 | https://conductscience.org/library/papers/1740667 | PubMed |
| 16 | 1314888 | Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. | J Exp Med | 1992 | https://conductscience.org/library/papers/1314888 | PubMed |
| 17 | 1533441 | Nuclear factor of activated T cells contains Fos and Jun. | Nature | 1992 | https://conductscience.org/library/papers/1533441 | PubMed |
| 18 | 1281217 | Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation. | J Exp Med | 1992 | https://conductscience.org/library/papers/1281217 | PubMed |
| 19 | 1281550 | Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1281550 | PubMed |
| 20 | 8428966 | Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8428966 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687675 | Association of Ferritin Levels With Cytokine Release Syndrome in CAR T-Cell Therapy: A Systematic Review and Meta-Analysis. | Cancer Med | 2026 | https://conductscience.org/library/papers/42687675 | PubMed |
| 42389534 | FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection. | Front Immunol | 2026 | https://conductscience.org/library/papers/42389534 | PubMed |
| 40088333 | Unlocking the therapeutic potential of the NFAT pathway in kidney diseases. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40088333 | PubMed |
| 39563446 | Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen species. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39563446 | PubMed |
| 39479216 | NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection. | Transpl Int | 2024 | https://conductscience.org/library/papers/39479216 | PubMed |
| 39379603 | Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors. | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/39379603 | PubMed |
| 39053944 | Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/39053944 | PubMed |
| 38785735 | Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency-Clinical and Immunotransplant Implications with a Review of the Literature. | Diseases | 2024 | https://conductscience.org/library/papers/38785735 | PubMed |
| 38635551 | Enhanced cytotoxic activity of natural killer cells from increased calcium influx induced by electrical stimulation. | PLoS One | 2024 | https://conductscience.org/library/papers/38635551 | PubMed |
| 37675125 | Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. | Front Immunol | 2023 | https://conductscience.org/library/papers/37675125 | PubMed |
| 36401631 | FK506 impairs neutrophil migration that results in increased polymicrobial sepsis susceptibility. | Inflamm Res | 2023 | https://conductscience.org/library/papers/36401631 | PubMed |
| 35774414 | Modularisation of published and novel models toward a complex KIR2DL4 pathway in pbNK cell. | MethodsX | 2022 | https://conductscience.org/library/papers/35774414 | PubMed |
| 35720368 | From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720368 | PubMed |
| 35671888 | Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein. | J Virol Methods | 2022 | https://conductscience.org/library/papers/35671888 | PubMed |
| 35550603 | The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation. | Exp Mol Med | 2022 | https://conductscience.org/library/papers/35550603 | PubMed |
| 35479087 | Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/35479087 | PubMed |
| 34908173 | Epigenetic regulation of natural killer cell memory. | Immunol Rev | 2022 | https://conductscience.org/library/papers/34908173 | PubMed |
| 34804035 | Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34804035 | PubMed |
| 33467027 | Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33467027 | PubMed |
| 33440654 | ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33440654 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
| NFATC1 | 4772 | PubTator's text mining | https://conductscience.org/library/genes/4772 | NCBI Gene |
| NFATC2 | 4773 | PubTator's text mining | https://conductscience.org/library/genes/4773 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7650486
GET https://conductscience.org/api/papers/v1/7650486/references?page=2